Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.
Sci Adv. 2023 Feb 10;9(6):eade9238. doi: 10.1126/sciadv.ade9238. Epub 2023 Feb 8.
Sci Adv. 2023.
PMID: 36753540
Free PMC article.
The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture.
Graca Marques J, Pavlovic B, Ngo QA, Pedot G, Roemmele M, Volken L, Kisele S, Perbet R, Wachtel M, Schäfer BW.
Graca Marques J, et al. Among authors: kisele s.
Cancer Res. 2024 Jan 16;84(2):241-257. doi: 10.1158/0008-5472.CAN-22-3950.
Cancer Res. 2024.
PMID: 37963210
Item in Clipboard
Loss of cIAP1 in Endothelial Cells Limits Metastatic Extravasation through Tumor-Derived Lymphotoxin Alpha.
Vasilikos L, Hänggi K, Spilgies LM, Kisele S, Rufli S, Wong WW.
Vasilikos L, et al. Among authors: kisele s.
Cancers (Basel). 2021 Feb 3;13(4):599. doi: 10.3390/cancers13040599.
Cancers (Basel). 2021.
PMID: 33546280
Free PMC article.
Item in Clipboard
Evaluation of the role of AXL in fusion-positive pediatric rhabdomyosarcoma identifies the small-molecule inhibitor bemcentinib (BGB324) as potent chemosensitizer.
Danielli SG, Wurth J, Morice S, Kisele S, Surdez D, Delattre O, Bode PK, Wachtel M, Schafer BW.
Danielli SG, et al. Among authors: kisele s.
Mol Cancer Ther. 2024 Mar 13. doi: 10.1158/1535-7163.MCT-23-0285. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38471796
Item in Clipboard
Cite
Cite